Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45

Evolent Health initiated with an Overweight at KeyBanc

KeyBanc analyst Donald Hooker started Evolent Health with an Overweight rating and $23 price target. The company offers an attractive way to play the transformation of U.S. healthcare to value-based reimbursement, the analyst contends.

  • 25

    Sep

EVH Evolent Health
$15.65

-0.8 (-4.86%)

09/06/17
JEFF
09/06/17
NO CHANGE
Target $28
JEFF
Buy
Jefferies calls Evolent 'easy buy' after management meeting
Jefferies analyst Sean Dodge says Evolent Health shares are down 27% since the company's Q2 results on August 7 due to "overblown concerns" around 2018 revenue growth and use of proceeds from the primary share offering. After meeting with management, the analyst notes Evolent remains confident in its long-term outlook and that there are multiple near-term catalyst for the shares. Dodge believes Evolent's revenue will grow 25%-plus in 2018, even without another new client, and the $175M capital raise "foreshadows some big contract wins." He sees "little chance" of another secondary offering now that private equity ownership is mostly removed. Valuation makes Evolent "an easy buy," Dodge tells investors. He recommends buying the shares and keeps a Buy rating on the name with a $28 price target.
08/18/17
LEER
08/18/17
NO CHANGE
Target $32
LEER
Outperform
Leerink views CMS proposal as only modest negative for Evolent
Leerink analyst David Larsen says shares of Evolent Health traded lower this week after the Centers for Medicare & Medicaid Service announced a proposed rule that scales back the Comprehensive Care for Joint Replacement model and cancels the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive payment model which were slated to begin in January 2018. The move by CMS is a "modest negative" for Evolent because cardiac care and joint replacements tend to be high revenue and earnings drivers for hospitals, Larsen tells investors in a research note. The analyst, however, remains positive on the shares. He believes that with or without these two programs, the industry-wide shift towards value-based care will continue. Larsen keeps an Outperform rating on Evolent with a $32 price target.
08/18/17
JPMS
08/18/17
NO CHANGE
JPMS
Overweight
Evolent Health 29% selloff this week overdone, says JPMorgan
JPMorgan analyst Stephanie Davis views the 29% selloff this week in shares of Evolent Health following the company's Q2 results as overdone. The analyst says the pullback is a buying opportunity. Davis, while acknowledging that FY18 is a larger contract renewal year for Evolent, notes the Q2 results did not change her long term thesis. The analyst continues to believe in the company's "superior positioning to win in the shift to value based care." She keeps an Overweight rating on Evolent Health.
08/08/17
BARD
08/08/17
NO CHANGE
Target $35
BARD
Outperform
Evolent Health shares inexpensive relative to growth, says Baird
Baird analyst Matthew Gillmor noted Evolent Health reported better than expected Q2 results and raised guidance. He said the pipeline is deep with large opportunities, yet he believes investors may be confused with regards to 2018 visibility. The analyst said shares are simply too inexpensive relative to the company's organic growth rate and he expects its valuation will reset higher at some point. Gillmor reiterated his Outperform rating and $35 price target on Evolent Health shares.

TODAY'S FREE FLY STORIES

15:10
08/21/18
08/21
15:10
08/21/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

PSTG

Pure Storage

$22.00

0.2 (0.92%)

15:04
08/21/18
08/21
15:04
08/21/18
15:04
Options
Pure Storage options imply 10.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 12

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

CASY

Casey's General Stores

$116.05

1.33 (1.16%)

15:01
08/21/18
08/21
15:01
08/21/18
15:01
Conference/Events
Casey's General Stores management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 17

    Sep

  • 06

    Nov

RIGL

Rigel Pharmaceuticals

$2.67

0.08 (3.09%)

15:00
08/21/18
08/21
15:00
08/21/18
15:00
Hot Stocks
Rigel's Rodriguez says 'work has just begun' with Tavalisse launch »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$127.21

-0.47 (-0.37%)

15:00
08/21/18
08/21
15:00
08/21/18
15:00
Options
Electronic Arts attracts a bullish option play »

Electronic Arts attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

URBN

Urban Outfitters

$47.40

-0.12 (-0.25%)

14:49
08/21/18
08/21
14:49
08/21/18
14:49
Options
Urban Outfitters options imply 12.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

SFIX

Stitch Fix

$34.77

1.92 (5.84%)

14:45
08/21/18
08/21
14:45
08/21/18
14:45
Options
Stitch Fix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 01

    Oct

ATVI

Activision Blizzard

$69.63

0.7 (1.02%)

14:40
08/21/18
08/21
14:40
08/21/18
14:40
Periodicals
Breaking Periodicals news story on Activision Blizzard »

M Science says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 12

    Sep

  • 13

    Sep

NURO

NeuroMetrix

$1.26

0.04 (3.28%)

, GSK

GlaxoSmithKline

$41.57

0.25 (0.61%)

14:32
08/21/18
08/21
14:32
08/21/18
14:32
Hot Stocks
NeuroMetrix receives $3.8M milestone payment under its pact with GSK »

NeuroMetrix (NURO)…

NURO

NeuroMetrix

$1.26

0.04 (3.28%)

GSK

GlaxoSmithKline

$41.57

0.25 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

14:30
08/21/18
08/21
14:30
08/21/18
14:30
General news
Canada Retail Sales Preview »

Canada Retail Sales…

14:25
08/21/18
08/21
14:25
08/21/18
14:25
General news
Treasury Option Action: more bond positioning »

Treasury Option Action:…

MDT

Medtronic

$95.02

4.96 (5.51%)

14:20
08/21/18
08/21
14:20
08/21/18
14:20
Recommendations
Medtronic analyst commentary  »

Medtronic momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 23

    Aug

  • 05

    Sep

  • 12

    Sep

MS

Morgan Stanley

$48.75

0.48 (0.99%)

14:20
08/21/18
08/21
14:20
08/21/18
14:20
Options
Mega option block in Morgan Stanley »

Mega option block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/21/18
08/21
14:17
08/21/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$2.65

0.06 (2.32%)

14:16
08/21/18
08/21
14:16
08/21/18
14:16
Hot Stocks
Rigel CEO says impact of any Trump policy still unclear »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/21/18
08/21
14:16
08/21/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$339.67

11.92 (3.64%)

, AAPL

Apple

$216.73

1.25 (0.58%)

14:07
08/21/18
08/21
14:07
08/21/18
14:07
Periodicals
Netflix testing how to bypass iTunes billing in 33 countries, TechCrunch says »

Netflix (NFLX) is…

NFLX

Netflix

$339.67

11.92 (3.64%)

AAPL

Apple

$216.73

1.25 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

UAL

United Continental

$86.00

0.765 (0.90%)

14:06
08/21/18
08/21
14:06
08/21/18
14:06
Periodicals
United's Kirby sees average airfares improving, Bloomberg reports »

As U.S. rivals offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

APO

Apollo Global

$34.44

0.22 (0.64%)

, BX

Blackstone

$36.48

-0.32 (-0.87%)

14:04
08/21/18
08/21
14:04
08/21/18
14:04
Periodicals
PE firms eyeing acquisitions of local TV assets, CNBC reports »

Apollo Global (APO),…

APO

Apollo Global

$34.44

0.22 (0.64%)

BX

Blackstone

$36.48

-0.32 (-0.87%)

NXST

Nexstar

$80.25

1.05 (1.33%)

TRCO

Tribune Media

$35.98

0.91 (2.59%)

SBGI

Sinclair Broadcast

$29.30

0.55 (1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 06

    Sep

UAL

United Continental

$86.32

1.085 (1.27%)

14:00
08/21/18
08/21
14:00
08/21/18
14:00
Options
Heavy call activity in UAL as shares take off »

Heavy call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RIGL

Rigel Pharmaceuticals

$2.66

0.07 (2.70%)

13:52
08/21/18
08/21
13:52
08/21/18
13:52
Hot Stocks
Rigel's Rodriguez says physician response to Tavalisse 'very positive' »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCI

Johnson Controls

$39.84

1.11 (2.87%)

13:50
08/21/18
08/21
13:50
08/21/18
13:50
Options
Notable call spread in Johnson Controls as shares rally »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$287.20

1.52 (0.53%)

, SPX

S&P 500

$0.00

(0.00%)

13:46
08/21/18
08/21
13:46
08/21/18
13:46
Periodicals
Michael Cohen enters plea deal with federal prosecutors, ABC News says »

Tom Llamas, ABC…

SPY

SPDR S&P 500 ETF Trust

$287.20

1.52 (0.53%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.35

0.5 (3.15%)

13:45
08/21/18
08/21
13:45
08/21/18
13:45
Options
GameStop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
08/21/18
08/21
13:40
08/21/18
13:40
General news
FOMC minutes preview: »

FOMC minutes preview: the…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.